Indena Boswellia formulation shown to alleviate IBS symptoms

c0a9d50b-0fb2-4101-93dc-21f851aa1f47articleimage.jpg

17 Jul 2017 --- A new study has shown that Casperome, the Indena Phytosome formulation of Boswellia serrate that delivers the full natural bouquet of triterpenoids, offers rapid relief to sufferers of irritable bowel syndrome (IBS). Affecting 10 to 20 percent of the adult population and often unrecognized or untreated, Irritable bowel syndrome (IBS) is a chronic, relapsing gastrointestinal disorder. 

The supplement registry study, published in the European Review for Medical and Pharmacological Sciences, enrolled 71 otherwise healthy subjects with idiopathic IBS that each decided to follow a different management strategy. Group one took Hyoscine butylbromide, administered when needed. Group two took 10mg of papaverine hydrochloride and 10mg of belladonna extract, administered when needed. Group three used a supplementation with Casperome, one tablet of 250mg per day, for four weeks. All groups were comparable in term of age and gender distribution and they presented similar clinical characteristics at inclusion. Abdominal pain, altered bowel movements, meteorism and cramps were evaluated by subjects before the inclusion and during the last week before the end of the observational period of four weeks.

All IBS symptoms investigated improved during the period with the three management strategies, but only in the Casperome-supplemented group did the number of subjects with any IBS symptoms significantly decrease, from 58 percent to 12.5 percent. In the Casperome-supplemented group, the number of subjects who needed medical attention significantly decreased to 4.1 percent. In addition, the prevalence of side effects was significantly higher in the two groups treated with the Standard Management Strategies (28 percent for group one and 26 percent for group two) compared to Casperome supplemented subjects (8.2 percent). 

This study demonstrates that Indena’s Casperome supplementation may represent a promising alternative approach to managing symptoms associated with IBS in otherwise healthy subjects.

Related Articles

Nutrition & Health News

Protein supplementation doesn’t help to keep weight off after weight loss, study suggests

19 Sep 2017 --- Protein supplementation does not result in improved weight management success or blood biochemistry after weight loss compared with the effects of normal dietary protein intake. This is according to a study sponsored by the University of Copenhagen and collaborated on by Danish companies Arla Foods and Nupo A/S.

Nutrition & Health News

Body’s own fat metabolism fights against harmful effects of sugar, study finds

19 Sep 2017 --- Researchers from Aarhus University in Denmark have discovered a metabolite that reveals how the body's fat metabolism provides protection against the harmful effects of sugar. The researchers have indicated this has the potential to explain the chemical link between a low-carbohydrate diet and healthy aging.

Food Ingredients News

Organic AstaPure astaxanthin verified by Non-GMO Project

19 Sep 2017 --- Algatechnologies’ organic Haematococcus pluvialis microalgae powder and astaxanthin oleoresin have been granted non-GMO verification by the Non-GMO Project. Algatech is the first astaxanthin manufacturer to attain this verification.

Nutrition & Health News

Sabinsa granted US patent for synbiotic composition of shelf-stable probiotic and cranberry fibers

18 Sep 2017 --- Sabinsa has been granted a US patent on the company’s shelf-stable probiotic LactoSpore in combination with cranberry seed fibers. The granted patent (US9717766) discloses a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 in a synbiotic composition containing natural plant fibers from Vaccinium oxycoccos (cranberry). The cranberry fibers in this composition were observed to increase the viable count of Bacillus coagulans MTCC 5856.

Nutrition & Health News

Safe use of Olygose GOS supported by new peer-reviewed publications

18 Sep 2017 --- French natural ingredients manufacturer Olygose has announced that new peer-reviewed publications support the safe use of plant-based galacto-oligosaccharides (GOS) from Olygose from infancy to older age.

More Articles
URL : http://www.nutritioninsight.com:80/news/indena-boswellia-formulation-shown-to-alleviate-ibs-symptoms.html